News from Zyme and the companies we work with.
DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction
FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies Paris, France, 04 August 2026: DNA Script, a pioneer in DNA synthesis [...]
Qureight closes $20 million Series B financing
Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further [...]
Leerink Partners Report Names Carterra a Core Enabler of the $7B “Lab-in-the-Loop” Antibody Discovery Market
New research on AI-driven biologics discovery identifies Carterra's high-throughput SPR platforms as central to the Lab-in-the-Loop (LitL) workflow reshaping drug discovery, with Twist Bioscience and Adaptyv Bio pointing to surging [...]
SynGenSys makes key appointments to strengthen senior commercial and scientific teams
Heads of Commercial, CHO Expression Technologies, Cell and Gene Therapy Expression Technologies, and Bioinformatics and Data Science appointed to support commercial scale-up Strengthens alignment between customer needs, product development, scientific [...]
EpilepsyGTx appoints Dr Teresa Nunes as Chief Medical Officer
Appointment of senior clinical leader will support progression of lead candidate EPY201 through the clinic London, UK, 22 JULY 2026: EpilepsyGTx, a biotechnology company focused on research and development of [...]
FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026
Annual event brings together international experts in antibody discovery and development, taking place September 16–18, 2026, in Évora, Portugal Porto, Portugal, 21 July 2026: FairJourney Bio (“FJBio”), a global antibody [...]
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France, 16 July 2026: DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis [...]
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
ClearPoint Neuro’s system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx’s investigational gene therapy Partnership will support first-in-human Phase 1/2a clinical trials of [...]
DDW introduces new series of events aimed at connecting innovation with investment in early-stage drug discovery
Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (London, UK, 4th November 2026, and Basel, Switzerland, March 2027) Focused on technology, innovation, and [...]
Camena Bioscience appoints Gregory P. McGuinness as CEO
Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discovery, [...]
Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe
Hamburg, DE, 07 JULY 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today [...]
Bio-Rad Launches Vericheck ddPCR Kits Compatible with QX700 Platform for Biopharma Quality Control and Cell and Gene Therapy Workflows
New Vericheck ddPCR™ Kits Combine Highly Specific and Highly Sensitive DNA Detection and Quantification with the QX700™ System’s Seven-Color Multiplexing, Simplified Workflow, and Scalable Throughput HERCULES, Calif.—July 07, 2026—Bio-Rad Laboratories, [...]
